Industry News

FDA Designates Opioid Overdose Treatment for Fast Track Development Program
FDA Notifies Not to Use Gold Vigra and Miraculous Evil Root: AttorneyOne Monitor and Keep Consumers Informed
Merck Serono selects Ventana Medical Systems, Inc. to Develop Companion Diagnostic Test for its Targeted Cancer Treatment
Merck Serono selects Ventana Medical Systems, Inc. to develop companion diagnostic test for its targeted cancer treatment
Orphan Drug Approvals Have Increased, But High Costs Pose Challenges for Patients, According to the Tufts Center for the Study of Drug Development
723 deaths due to lack of snake anti-venom
GLENMARK TO LAUNCH ANTI-HYPERTENSION DRUG IN US
Perrigo Announces FDA Final Approval For The Store Brand Equivalent To Advil Congestion Relief Tablets, 200 mg/10 mg
FDA Approves Anacor Pharmaceuticals (Tavaborole) Topical Solution, 5% for the Treatment of Onychomycosis of the Toenails
Valeant Pharmaceuticals Completes Acquisition Of PreCision Dermatology
Mylan Launches Generic Micardis Tablets
Perrigo Announces FDA Final Approval For The Store Brand Equivalent To Advil� Congestion Relief Tablets, 200 mg/10 mg
FDA Approves Anacor Pharmaceuticals� KERYDIN� (Tavaborole) Topical Solution, 5% for the Treatment of Onychomycosis of the Toenails
Valeant Pharmaceuticals Completes Acquisition Of PreCision Dermatology
Mylan Launches Generic Micardis� Tablets
Ruvo Center: We are not meeting the challenge of curing Alzheimer's disease
Teva Reaches Settlement in ProAir� HFA Patent Case Teva Pharmaceutical Industries Ltd.
BioMarin Announces Health Canada Approval of VIMIZIM� (elosulfase alfa) for the Treatment of Morquio A Syndrome
FDA Grants Spectrum Pharmaceuticals Accelerated Approval of Beleodaq� (belinostat) for Injection
NAFDAC Clamps Down on Manufacturers of Antibiotics, Anti-Malarials Without Mobile Authentication
Merz to Acquire Ulthera
Dallen Medical Secures FDA Clearance for Disposable Compressyn Staple Delivery System for Small Bone Fixation
Scrutiny of chemical triclosan could lead to FDA rules by 2018
United States : ANI PHARMA declares acquisition of Lithobid tablets from NOVEN THERAPEUTICS
Medtronic Announces Class I Recall Of Duet Neuro Drainage And Monitoring Systems